Ambeed.cn

首页 / 抑制剂/激动剂 / 代谢酶 / 脂氧合酶 / Zileuton

齐留通 /Zileuton {[allProObj[0].p_purity_real_show]}

货号:A202709 同义名: 齐留通(Zileuton) / A 64077;Abbott 64077

Zileuton is a reversible 5-lipoxygenase inhibitor with IC50 value of 0.5 µM in rat basophilic leukemia-1 (RBL-1) cells. It also potently inhibited leukotriene B4 production with an IC50 value of 0.6 µM in purified human peripheral blood polymorphonuclear leukocytes (PMNL).

Zileuton 化学结构 CAS号:111406-87-2
Zileuton 化学结构
CAS号:111406-87-2
Zileuton 3D分子结构
CAS号:111406-87-2
Zileuton 化学结构 CAS号:111406-87-2
Zileuton 3D分子结构 CAS号:111406-87-2
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Zileuton 纯度/质量文件 产品仅供科研

货号:A202709 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nat. Biomed. Eng., 2024, 8, 1412-1424. Ambeed. [ A538667 , A631746 ]
JMC, 2024. Ambeed. [ A833302 , A475501 , A341986 , A356070 ]
BMC Cancer, 2024, 24(1): 1415. Ambeed. [ A809692 , A209020 ]
J. Am. Soc. Mass Spectrom., 2024, 35(12): 3192-3202. Ambeed. [ A166127 , A902473 , A753371 , A961334 , A292945 , A230770 , A300620 , A1114580 , A1159765 , A206238 ]
PloS One, 2024, 19(11): e0308060. Ambeed. [ A302917 ]
更多 >
产品名称 lipoxygenase 其他靶点 纯度
Zileuton 97%
Nordihydroguaiaretic acid 99%+
MK-886 99%+
Esculetin 98%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

Zileuton 生物活性

靶点
  • lipoxygenase

描述 Leukotrienes (LT) are metabolites of arachidonic acid (AA) formed from the 5-lipoxygenase (5-LOX) pathway. They exhibit a number of biological effects such as contraction of smooth muscles, especially bronchoconstriction, increased vascular permeability, and migration of leukocytes to areas of inflammation. Zileuton is a potent and selective inhibitor of 5-lipoxygenase with antiasthmatic properties[3]. In macrophages, zileuton overinterfered with arachidonic acid (AA) release to inhibit PG biosynthesis. In activated mouse peritoneal macrophages and macrophage J774, zileuton significantly reduces PGE2 and 6-ketone prostaglandin F1α (PGF1α) levels[4]. In anti-CD3-treated cells, IL-2 decreased in zileuton-treated and untreated cells with increasing incubation time. Zileuton likely reduced IL-2 levels by inhibiting 5-lipoxygenase[3]. Zileuton treatement on rats with TNB colitis, however, showed a significant reduction in the macroscopic damage score after four weeks of treatment compared with 5-ASA and placebo groups. The intracolonic administration of 50 mg/kg of zileuton after colitis induction decreased the local peak release of LTB4 by 90%[5]. In zileuton (5 mg/kg, p.o.) treated ischemia/reperfusion (I/R) rat, the effect of zileuton to decrease NF-κB expression did not change significantly in the presence of COX inhibitors, and the group revealed significantly lower level of NF-κB staining. Zileuton (5 mg/kg, p.o.) treatment given to I/R rats decreased apoptotic index significantly. In 5-LOX gene knockout mice, administration of zileuton before I/R significantly reduced the degree of renal dysfunction (urea, creatinine) and injury (AST, histology). In addition, zileuton reduced the expression of ICAM-1 and the associated polymorphonuclear leukocyte infiltration caused by I/R of the mouse kidney[6]. Although zileuton inhibited LTB4 production in the peritonitis model more effectively than the LTA4H inhibitor, the influx of neutrophils into the peritoneum after 1 and 2h was significantly higher in zileuton- versus JNJ-26993135-treated animals[7].

Zileuton 动物研究

Dose Mice: 10 mg/kg[3] (i.p.); 50 mg/kg[4] (p.o.) Rat: 1 mg/kg, 3 mg/kg[5] (i.v.)
Administration i.p., i.v., p.o.

Zileuton 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT00595114 - Completed - United States, Massachusetts ... 展开 >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 收起 <<
NCT00595114 - Completed - -
NCT01125748 - Completed - -

Zileuton 参考文献

[1]Rossi A, Pergola C, et al. The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages. Br J Pharmacol. 2010 Oct;161(3):555-70.

[2]Bertran X, Mane J, et al. Intracolonic administration of zileuton, a selective 5-lipoxygenase inhibitor, accelerates healing in a rat model of chronic colitis. Gut. 1996 Jun;38(6):899-904.

[3]Abueid L, Uslu Ü, Cumbul A, Velioğlu Öğünç A, Ercan F, Alican İ. Inhibition of 5-lipoxygenase by zileuton in a rat model of myocardial infarction. Anatol J Cardiol. 2017 Apr;17(4):269-275. doi: 10.14744/AnatolJCardiol.2016.7248. Epub 2016 Nov 10. PMID: 27849187; PMCID: PMC5469106.

[4]Rossi A, Pergola C, Koeberle A, Hoffmann M, Dehm F, Bramanti P, Cuzzocrea S, Werz O, Sautebin L. The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages. Br J Pharmacol. 2010 Oct;161(3):555-70. doi: 10.1111/j.1476-5381.2010.00930.x. PMID: 20880396; PMCID: PMC2990155.

[5]Bertrán X, Mañé J, Fernández-Bañares F, Castellá E, Bartolí R, Ojanguren I, Esteve M, Gassull MA. Intracolonic administration of zileuton, a selective 5-lipoxygenase inhibitor, accelerates healing in a rat model of chronic colitis. Gut. 1996 Jun;38(6):899-904. doi: 10.1136/gut.38.6.899. PMID: 8984030; PMCID: PMC1383199.

[6]Patel NS, Cuzzocrea S, Chatterjee PK, Di Paola R, Sautebin L, Britti D, Thiemermann C. Reduction of renal ischemia-reperfusion injury in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton. Mol Pharmacol. 2004 Aug;66(2):220-7. doi: 10.1124/mol.66.2.220. PMID: 15266012.

[7]Rao NL, Dunford PJ, Xue X, Jiang X, Lundeen KA, Coles F, Riley JP, Williams KN, Grice CA, Edwards JP, Karlsson L, Fourie AM. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton. J Pharmacol Exp Ther. 2007 Jun;321(3):1154-60. doi: 10.1124/jpet.106.115436. Epub 2007 Mar 19. PMID: 17371808.

Zileuton 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.23mL

0.85mL

0.42mL

21.16mL

4.23mL

2.12mL

42.32mL

8.46mL

4.23mL

Zileuton 技术信息

CAS号111406-87-2
分子式C11H12N2O2S
分子量 236.29
别名 齐留通(Zileuton) ;A 64077;Abbott 64077;ZYFLO CR.;trade name ZYFLO;ZYFLO
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Keep in dark place,Sealed in dry,Room Temperature

溶解度

DMSO: 105 mg/mL(444.37 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。